Immunowake Funding & Investors

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies. Immunotherapy involves harnessing the body’s immune system to identify and kill cancer cells in the same way pathogens are identified and targeted. Recent breakthroughs in cancer immunotherapy have demonstrated that powerful anti-tumor responses can be achieved by activating antigen-specific T-cells.